A. Neil Howell
Corporate Officer/Principal bei University of Texas Medical Branch
Profil
A.
Neil Howell joined MIGENIX, Inc. in August 2004 as Vice President of Research.
Previously, he had served as Vice President of Research at MitoKor in 2000.
He was a tenured Professor in the Department of Radiation Oncology at the University of Texas Medical Branch at Galveston, where he serves as an Adjunct Professor.
Dr. Howell held several professorial positions at the University of Texas Medical Branch in Galveston and at Harvard Medical School.
He was a Member of the Grant Review Committees at the National Institutes of Health and the National Science Foundation.
Dr. Howell received a BA from the University of Kansas and a PhD in Molecular Biology from the University of Wisconsin.
Aktive Positionen von A. Neil Howell
| Unternehmen | Position | Beginn |
|---|---|---|
| University of Texas Medical Branch | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von A. Neil Howell
| Unternehmen | Position | Ende |
|---|---|---|
MIGENIX, Inc.
 MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada. | Technik-/Wissenschafts-/F&E-Leiter | - |
MitoKor, Inc.
 MitoKor, Inc. BiotechnologyHealth Technology MitoKor, Inc. provided discovery and diagnostic development of mitochondrial medicine. It was a biotechnology company focused on the research and development of drugs for the treatment of major diseases and conditions associated with mitochondrial dysfunction. The company was headquartered in San Diego, CA | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von A. Neil Howell
| University of Kansas | Undergraduate Degree |
| University of Wisconsin | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
MitoKor, Inc.
MitoKor, Inc. BiotechnologyHealth Technology MitoKor, Inc. provided discovery and diagnostic development of mitochondrial medicine. It was a biotechnology company focused on the research and development of drugs for the treatment of major diseases and conditions associated with mitochondrial dysfunction. The company was headquartered in San Diego, CA | Health Technology |
MIGENIX, Inc.
MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada. | Health Technology |
